Legislative Activity

The Radiology Outpatient Ordering Transmission (ROOT) Act updates Medicare requirements for ordering advanced diagnostic imaging services. It mandates changes to how clinical decision support (CDS) systems report data directly to the government, starting in 2026. The bill also establishes new tracking mechanisms for identifying and reviewing "low compliant" ordering professionals. Finally, it provides specific exemptions to the consultation requirement for certain preventive scans and rural providers.

The Michael Enzi Voluntary Protection Program Act establishes a new, free federal recognition program administered by the Secretary of Labor to honor employers who demonstrate exemplary commitment to workplace safety and health. Companies must implement robust safety systems to qualify for this recognition, which exempts them from programmed OSHA inspections. The Act mandates specific oversight, evaluation procedures, and a two-year timeline for the Secretary to finalize rules and transition existing voluntary programs.

The Drug Shortage Compounding Patient Access Act of 2025 aims to improve patient access to necessary medications during drug shortages. It allows pharmacists and physicians to compound urgent batches of drugs without an individual prescription if the drug is on the shortage list and commercial alternatives are unavailable. Furthermore, the bill enhances drug shortage mitigation by requiring manufacturers to report sudden surges in demand to the FDA, alongside existing reporting for manufacturing interruptions. Finally, it clarifies compounding regulations and adds specific labeling requirements for patient-specific compounded drugs.

The 5G UPGRADE Act of 2025 establishes strict, accelerated timelines for state and local governments to review requests for modifications to existing wireless facilities. If a government fails to approve or formally deny an eligible facilities request within 60 days, the request is automatically approved. This legislation aims to streamline the deployment of 5G infrastructure by limiting bureaucratic delays.

The Prescription Information Modernization Act of 2025 allows drug manufacturers to provide required prescribing information to healthcare providers digitally. This shift is contingent upon manufacturers offering providers the option to receive paper copies upon request, free of charge. The Secretary of HHS must establish final rules for this digital transition within one year of enactment.

The RESTORE Act aims to improve reproductive health care by promoting access to restorative reproductive medicine and fertility awareness-based methods. It directs federal agencies to review standards of care, expand relevant research, and update medical coding to ensure accurate classification and reimbursement for these treatments. Furthermore, the bill protects healthcare providers from discrimination based on their refusal to participate in assisted reproductive technology.

The Pregnancy.Gov Act establishes a new national public website, Pregnancy.gov, to serve as a centralized hub connecting pregnant women with local resources. This site must offer tailored resource matching based on location and ensure listed providers have a consistent three-year service history. Crucially, the Act prohibits any organization that performs, refers for, or counsels in favor of abortion from being listed or receiving associated state grants.

The Universal Savings Account Act of 2025 establishes a new tax-advantaged savings vehicle called a Universal Savings Account (USA). These accounts allow for annual contributions, which are subject to an indexed limit starting at \$10,000 for 2025, with distributions generally being tax-free. The bill outlines specific rules for trustees, asset management, rollovers, and penalties for excess contributions.

The Seniors’ Access to Critical Medications Act of 2025 temporarily modifies the physician self-referral prohibition (Stark Law) to allow physician practices to dispense certain Medicare Part D prescription drugs directly to their patients between 2026 and 2030. This exception is subject to specific conditions regarding prescribing, patient history, and dispensing location. The bill also mandates a GAO study to examine trends in physician office drug dispensing and makes a minor adjustment to the allocation for the Medicare Improvement Fund.

The American Music Tourism Act of 2025 directs the Assistant Secretary of Commerce for Travel and Tourism to actively promote domestic and international travel focused on U.S. music heritage and events. This includes identifying key music tourism locations and streamlining international visitor access to these sites. The Act also establishes new biennial reporting requirements to Congress detailing progress on these tourism goals.

The MAIN Event Ticketing Act significantly strengthens the BOTS Act to crack down on automated ticket buying by explicitly banning the use of software to bypass ticket purchasing rules. This legislation imposes new mandatory security and reporting requirements on ticket sellers to protect their systems and customer data from circumvention. Violators face substantially increased civil penalties, and the FTC is empowered to enforce these new standards.

The Fair Access In Residency (FAIR) Act of 2025 aims to ensure equitable treatment of osteopathic (D.O.) and allopathic (M.D.) medical school graduates in residency applications. It requires hospitals receiving Medicare funds to report detailed data on D.O. and M.D. applicants and acceptances for each residency program. Hospitals failing to submit this required data will face a 2% reduction in their Medicare payments. This collected data will also be made publicly available to promote transparency in the residency recruitment process.

This bill aims to create national uniformity for preterm infant formula by temporarily freezing state regulations that differ from federal standards for two years. It mandates a study by the FDA to review the availability and rules surrounding this specialized formula, including whether premarket approval should be required. The temporary freeze on state rules does not prevent lawsuits or criminal charges against manufacturers for willful misconduct that causes serious harm or death.

The United States-Abraham Accords Cooperation and Security Act of 2025 directs the FDA to establish an Abraham Accords Office to strengthen international oversight of FDA-regulated products by providing technical assistance and facilitating communication between the FDA and Abraham Accords countries. Within two years, the Secretary of Health and Human Services must select a location for the office in an Abraham Accords country. The Secretary must submit a report to Congress within three years on the Abraham Accords Office. This act aims to align regulatory requirements and improve coordination between the FDA and entities in Abraham Accords countries.

The "One Flag for All Act" generally prohibits the display of flags other than the U.S. flag on the exterior or in public areas of covered federal buildings. There are explicit exceptions for flags such as POW/MIA flags, state flags displayed at a Member of Congress's office, flags representing the Armed Forces, flags of historical significance, and flags representing local jurisdictions where the building is located. The bill defines "covered public buildings" broadly, including federal buildings, Senate and House buildings, military installations, and U.S. embassies and consulates.

The "Rural Physician Workforce Production Act of 2025" aims to boost the number of physicians practicing in rural areas by establishing a new payment system to support medical resident training in those locations. This includes an "elective rural sustainability per resident payment" to hospitals training residents in rural areas and adjusts graduate medical education funding to further support rural training programs. The Act ensures that hospitals training residents in rural areas receive additional financial support, without being subject to existing program limitations, to cover the costs of training. It also includes provisions to maintain budget neutrality within Medicare's medical education spending.

This bill disapproves and nullifies the Environmental Protection Agency's final rule regarding Trichloroethylene (TCE) regulation under the Toxic Substances Control Act (TSCA).

This bill nullifies the FDA's January 2023 modifications to the risk evaluation and mitigation strategy (REMS) for mifepristone, an abortion pill. It also prevents the Secretary of Health and Human Services from creating or enforcing similar regulations related to mifepristone's distribution.

This bill disapproves and nullifies the Environmental Protection Agency's rule regarding Trichloroethylene (TCE) regulation under the Toxic Substances Control Act.